Daphna Levy
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
- Oncology 6
- CAR-T cell therapy research 5
- Peptidase Inhibition and Analysis 1
-
- Immunotherapy and Immune Responses 3
- T-cell and B-cell Immunology 1
- Immune Cell Function and Interaction 1
- Co-authors
- Gal Markel (6 shared papers)Jacob Schachter (6 shared papers)Michal Judith Besser (6 shared papers)Orit Itzhaki (5 shared papers)Avraham J. Treves (4 shared papers)Ronnie Shapira-Frommer (4 shared papers)Adva Kubi (4 shared papers)Bruria Shalmon (3 shared papers)
- Journals
- Clinical Cancer Research (2 papers)Biomarkers (1 paper)PLoS ONE (1 paper)Cancer Immunology Immunotherapy (1 paper)Journal of Immunotherapy (1 paper)
- Partner nations
- IsraelUnited StatesAustralia
In The Last Decade
Daphna Levy
7 papers receiving 959 citations
Peers
Comparison fields: 5 of 39
- Oncology 798
- Immunology 609
- Genetics 172
- Cancer Research 46
- Biotechnology 27
Countries citing papers authored by Daphna Levy
This map shows the geographic impact of Daphna Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daphna Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daphna Levy more than expected).
Fields of papers citing papers by Daphna Levy
This network shows the impact of papers produced by Daphna Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daphna Levy. The network helps show where Daphna Levy may publish in the future.
Co-authors
The 25 scholars most cited alongside Daphna Levy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 388 | |
| 2 | 2013 | 328 | |
| 3 | 2011 | 142 | |
| 4 | 2012 | 43 | |
| 5 | 2013 | 41 | |
| 6 | 2012 | 20 | |
| 7 | 2012 | 18 |
About Daphna Levy
Daphna Levy is a scholar working on Oncology, Immunology, Cancer Research, Pathology and Forensic Medicine and Genetics, having authored 7 papers that have together received 980 indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), Immunotherapy and Immune Responses (3 papers), Cancer Mechanisms and Therapy (1 paper), MicroRNA in disease regulation (1 paper), Virus-based gene therapy research (1 paper), T-cell and B-cell Immunology (1 paper), Immune Cell Function and Interaction (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Oncology (798 citations), Immunology (609 citations), Genetics (172 citations), Cancer Research (46 citations) and Biotechnology (27 citations). Daphna Levy has collaborated with scholars based in Israel, United States and Australia. Frequent co-authors include Gal Markel, Jacob Schachter, Michal Judith Besser, Orit Itzhaki, Avraham J. Treves, Ronnie Shapira-Frommer, Adva Kubi, Bruria Shalmon, Arnon Nagler and Sara Apter. Their work appears in journals such as Clinical Cancer Research, Biomarkers, PLoS ONE, Cancer Immunology Immunotherapy and Journal of Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.